MYC and cancer: Gene amplification is the most commonly observed alteration in cancer for the MYC gene family, and MYCN amplification is found particularly in NB [159] in about 25% of diagnosed cases and is strongly associated with poor prognosis, thereby being a defining feature of high-risk NB [2,6,10,179].